Boldenox PHARMAX – 250mg/ml (10ml)


Generic name – boldenone undecylenate


Boldenox PHARMAX – 250mg/ml (10ml)

Generic name – boldenone undecylenate

Boldenox with generic basis of Boldenone Undecylenate is used mostly as supportive medication for veterinary treatments. Its basis is equal to Dianabol but lacks 17-alpha-methyl group.

It has strong anabolic and androgenic effects. It also has lower estrogenic activity and no progestogenic activity. It does not have any risk of hepatotoxicity. It has a longer carbon atom than decanoate. The rest of the factors are common as all the other anabolic androgenic steroids.

The main advantage of boldenone base is, that it does not aromatize and has no progestogen activity. That means no water retention and estrogen productions, no gynecomastia, if product is taken according to plan.

Product has a 14 days long half-life and is based on testosterone.

Dosage of Bolde 250

The cycle should be 10 weeks long and dosed in between 200 to 1000 mg per week for men and 50 to 150 mg per week for women, with interval between injections 5 – 7 days.

This product is ideal for longer cycles so if persistence of 10 weeks in impossible, advised minimal cycle is minimum of 8 weeks.

Effects of the product are:

Change in shape, size and appearance of muscles

Improvement in appearance and the number of muscle fibers

Protection of the muscles from catabolic functions (body reducing muscles for energy)

Increase of erythropoiesis (red blood cell production) in kidneys, which results in better blood oxygenation, which results in better endurance, cardio etc.

Improves muscle recovery from intensive workout.

Increases aggression and over all 'workout related drive'.

Common side effects of Testosterone based products with strong androgenic potency (such Bolde is) are:

oily skin, ance and body/facial hair growth


aggravation of male baldness


There are no reviews yet.

Be the first to review “Boldenox PHARMAX – 250mg/ml (10ml)”

Your email address will not be published. Required fields are marked *